Gustavo D. Lopardo

Buenos Aires, C, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

VOGUE: Noninferior Efficacy of Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults With HIV-1 Naive to Treatment.

VOGUE: Noninferior Efficacy of Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults With HIV-1 Naive to Treatment.

Journal: Open forum infectious diseases

Published: June 05, 2026

One year of the Latin American Alliance in Infectious Diseases and Clinical Microbiology: achievements and future challenges.

One year of the Latin American Alliance in Infectious Diseases and Clinical Microbiology: achievements and future challenges.

Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)

Published: April 08, 2025

Prevalence of Doravirine Resistance Mutations in a Large-Scale HIV-1 Transmitted Drug Resistance Survey in Buenos Aires, Argentina.

Prevalence of Doravirine Resistance Mutations in a Large-Scale HIV-1 Transmitted Drug Resistance Survey in Buenos Aires, Argentina.

Journal: Viruses

Published: April 07, 2025

Infectious diseases prevention and vaccination in migrants in Latin America: The challenges of transit through the treacherous Darien gap, Panama.

Infectious diseases prevention and vaccination in migrants in Latin America: The challenges of transit through the treacherous Darien gap, Panama.

Journal: Travel medicine and infectious disease

Published: March 20, 2025

Clinical and epidemiological characteristics of the 2022-2023 Mpox outbreak in Buenos Aires, Argentina.

Clinical and epidemiological characteristics of the 2022-2023 Mpox outbreak in Buenos Aires, Argentina.

Journal: Medicina

Published: February 03, 2025

Immune response induced by the recombinant novel coronavirus vaccine (Adenovirus type 5 vector) (Ad5-nCoV) in persons living with HIV (PLWH).

Immune response induced by the recombinant novel coronavirus vaccine (Adenovirus type 5 vector) (Ad5-nCoV) in persons living with HIV (PLWH).

Journal: PloS one

Published: October 23, 2024

Dual therapy based on co-formulated darunavir/ritonavir plus lamivudine for initial therapy of HIV infection: The ANDES randomized controlled trial.

Dual therapy based on co-formulated darunavir/ritonavir plus lamivudine for initial therapy of HIV infection: The ANDES randomized controlled trial.

Journal: International journal of antimicrobial agents

Published: January 26, 2024

Understanding the Burden of Respiratory Syncytial Virus in Older Adults in Latin America: An Expert Perspective on Knowledge Gaps.

Understanding the Burden of Respiratory Syncytial Virus in Older Adults in Latin America: An Expert Perspective on Knowledge Gaps.

Journal: Pulmonary therapy

Published: December 19, 2023

Comparative analysis of clinical characteristics, evolution and mortality of hospitalized patients with COVID-19 during the first and second wave of the pandemic (ECCOVID Study)

Comparative analysis of clinical characteristics, evolution and mortality of hospitalized patients with COVID-19 during the first and second wave of the pandemic (ECCOVID Study)

Journal: Medicina

Published: August 15, 2023

Human monkeypox: epidemiological and clinical characteristics of a series of cases

Human monkeypox: epidemiological and clinical characteristics of a series of cases

Journal: Medicina

Published: August 15, 2023

The global challenges of the long COVID-19 in adults and children.

The global challenges of the long COVID-19 in adults and children.

Journal: Travel medicine and infectious disease

Published: June 05, 2023

Latin America: Situation and preparedness facing the multi-country human monkeypox outbreak.

Latin America: Situation and preparedness facing the multi-country human monkeypox outbreak.

Journal: Lancet regional health. Americas

Published: July 11, 2022

Showing 1-12 of 43

Last Updated: 09/26/2026